A detailed history of Marathon Trading Investment Management LLC transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Marathon Trading Investment Management LLC holds 19,116 shares of BDTX stock, worth $55,818. This represents 0.02% of its overall portfolio holdings.

Number of Shares
19,116
Previous 94,400 79.75%
Holding current value
$55,818
Previous $478,000 81.38%
% of portfolio
0.02%
Previous 0.2%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$4.65 - $7.39 $350,070 - $556,348
-75,284 Reduced 79.75%
19,116 $89,000
Q1 2024

May 10, 2024

BUY
$2.67 - $5.74 $252,048 - $541,856
94,400 New
94,400 $478,000

Others Institutions Holding BDTX

About Black Diamond Therapeutics, Inc.


  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $106M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Marathon Trading Investment Management LLC Portfolio

Follow Marathon Trading Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.